MedTrace Logo

Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation

NCT06045364 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2024-09-05

No results posted yet for this study

Summary

This study aims to determine the role of Glycopyrrolate in preventing postoperative nausea and vomiting of ERCP.

Conditions

  • Nausea and Vomiting

Interventions

DRUG

Glycopyrrolate

During induction of anesthesia, 0.2mg Glycopyrrolate was given intravenously

DRUG

Anisodamine

During induction of anesthesia,10mg of Anisodamine was given intramuscular injection.

Sponsors & Collaborators

  • Jie Chen

    lead OTHER

Principal Investigators

  • Guangyou Duan, doctor · The Second Affiliated Hospital of Chongqing Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2024-07-20
Completion
2024-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06045364 on ClinicalTrials.gov